These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37724808)

  • 1. ceRNA networks in gynecological cancers progression and resistance.
    Wu S; Zhong B; Yang Y; Wang Y; Pan Z
    J Drug Target; 2023 Dec; 31(9):920-930. PubMed ID: 37724808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing Endogenous RNAs (ceRNAs) in Colorectal Cancer: A Review.
    Akhbari MH; Zafari Z; Sheykhhasan M
    Expert Rev Mol Med; 2022 Jun; 24():e27. PubMed ID: 35748050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.
    Liu D; Yu X; Wang S; Dai E; Jiang L; Wang J; Yang Q; Yang F; Zhou S; Jiang W
    Oncotarget; 2016 Aug; 7(35):57228-57238. PubMed ID: 27528026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing endogenous RNAs in lung cancer.
    Zhao M; Feng J; Tang L
    Cancer Biol Med; 2021 Feb; 18(1):1-20. PubMed ID: 33628581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
    Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
    Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
    Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
    Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ceRNA in cancer: possible functions and clinical implications.
    Qi X; Zhang DH; Wu N; Xiao JH; Wang X; Ma W
    J Med Genet; 2015 Oct; 52(10):710-8. PubMed ID: 26358722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNAs predict the survival of patients with colorectal cancer as revealed by constructing an endogenous RNA network using bioinformation analysis.
    Zhang H; Wang Z; Wu J; Ma R; Feng J
    Cancer Med; 2019 Mar; 8(3):863-873. PubMed ID: 30714675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
    Luo Q; Cui M; Deng Q; Liu J
    Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the ceRNA Network.
    Zhao Y; Song X; Song X; Xie L
    Pathol Oncol Res; 2022; 28():1610493. PubMed ID: 36185995
    [No Abstract]   [Full Text] [Related]  

  • 17. Construction of an oesophageal cancer-specific ceRNA network based on miRNA, lncRNA, and mRNA expression data.
    Xue WH; Fan ZR; Li LF; Lu JL; Ma BJ; Kan QC; Zhao J
    World J Gastroenterol; 2018 Jan; 24(1):23-34. PubMed ID: 29358879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hub lncRNA ceRNAs in multiple sclerosis based on ceRNA mechanisms.
    Ding Y; Li T; Yan X; Cui M; Wang C; Wang S; Zhang F; Zhang R
    Mol Genet Genomics; 2021 Mar; 296(2):423-435. PubMed ID: 33507382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
    Chiu YC; Hsiao TH; Chen Y; Chuang EY
    BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
    Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
    Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.